首页> 外文期刊>International Journal of Clinical Oncology >Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment
【24h】

Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment

机译:中度肾功能不全可能不需要降低顺铂剂量:一项对患有肾功能不全的癌症患者的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective The aim of this study was to assess the tolerability of cisplatin (CDDP) in patients with moderate renal dysfunction.
机译:目的本研究旨在评估中度肾功能不全患者的顺铂(CDDP)耐受性。

著录项

  • 来源
    《International Journal of Clinical Oncology》 |2013年第6期|977-982|共6页
  • 作者单位

    Division of Pharmacy National Cancer Center Hospital East">(1);

    Division of Thoracic Oncology National Cancer Center Hospital East">(2);

    Division of Oncology/Hematology National Cancer Center Hospital East">(3);

    Division of Gastrointestinal Oncology National Cancer Center Hospital East">(4);

    Division of Pharmacy National Cancer Center Hospital East">(1);

    Division of Thoracic Oncology National Cancer Center Hospital East">(2);

    Division of Pharmacy National Hospital Organization Tokyo Medical Center">(5);

    Division of Biostatistics Tohoku University Graduate School of Medicine">(6);

    Division of Pharmacy National Cancer Center Hospital East">(1);

    Department of Drug Safety Management Meiji Pharmaceutical University">(7);

    Division of Pharmacy National Cancer Center Hospital East">(1);

    Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine">(8);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Cisplatin; Renal impairment; Serum creatinine;

    机译:顺铂;肾功能不全;血清肌酐;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号